The Protective Efficacy of Single-Dose Nasal Immunization with Cold-Adapted Live-Attenuated MERS-CoV Vaccine Against Lethal MERS-CoV Infections in Mice

Overview

Journal Vaccines (Basel)

Date 2023 Aug 26

PMID 37631921

Authors

Heejeong Seo

Yunyueng Jang

Dongmi Kwak

Affiliations

Soon will be listed here.

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe diseases in humans. Camels act as intermediate hosts for MERS-CoV. Currently, no licensed vaccine is available for this virus. We have developed a potential candidate vaccine for MERS-CoV using the cold adaptation method. We cultivated the vaccine in Vero cells at temperatures as low as 22 °C. This live-attenuated vaccine virus showed high attenuation levels in transgenic mice with the MERS-CoV human receptor, dipeptidyl peptidase 4 (DPP4) (K18-hDPP4). The inoculated K18-hDPP4 mice exhibited no clinical signs such as death or body weight loss. Furthermore, no traces of infectious virus were observed when the tissues (nasal turbinate, brain, lung, and kidney) of the K18-hDPP4 mice infected with the cold-adapted vaccine strain were tested. A single intranasal dose of the vaccine administered to the noses of the K18-hDPP4 mice provided complete protection. We did not observe any deaths, body weight loss, or viral detection in the tissues (nasal turbinate, brain, lung, and kidney). Based on these promising results, the developed cold-adapted, attenuated MERS-CoV vaccine strain could be one of the candidates for human and animal vaccines.

Citing Articles

Viral Live-Attenuated Vaccines (LAVs): Past and Future Directions.

Tang Y, Li Y, Cai X, Yin X Adv Sci (Weinh). 2024; 12(3):e2407241.

PMID: 39639853 PMC: 11744563. DOI: 10.1002/advs.202407241.

Cold-adapted live attenuated MERS-CoV vaccine strain remains attenuated in mice after multiple passages in Vero cells at 37 °C.

Seo H, Jang Y Arch Microbiol. 2024; 206(10):393.

PMID: 39240318 DOI: 10.1007/s00203-024-04120-2.

Inactivated Split MERS-CoV Antigen Prevents Lethal Middle East Respiratory Syndrome Coronavirus Infections in Mice.

Seo H, Jang Y, Kwak D Vaccines (Basel). 2024; 12(4).

PMID: 38675818 PMC: 11053775. DOI: 10.3390/vaccines12040436.

References

Drosten C, Seilmaier M, Corman V, Hartmann W, Scheible G, Sack S . Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection. Lancet Infect Dis. 2013; 13(9):745-51. PMC: 7164791. DOI: 10.1016/S1473-3099(13)70154-3. View

Wang Q, Qi J, Yuan Y, Xuan Y, Han P, Wan Y . Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014; 16(3):328-37. PMC: 7104937. DOI: 10.1016/j.chom.2014.08.009. View

Bailey-Elkin B, Knaap R, Johnson G, Dalebout T, Ninaber D, van Kasteren P . Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression. J Biol Chem. 2014; 289(50):34667-82. PMC: 4263872. DOI: 10.1074/jbc.M114.609644. View

Seo S, Jang Y . Cold-Adapted Live Attenuated SARS-Cov-2 Vaccine Completely Protects Human ACE2 Transgenic Mice from SARS-Cov-2 Infection. Vaccines (Basel). 2020; 8(4). PMC: 7712048. DOI: 10.3390/vaccines8040584. View

Raj V, Mou H, Smits S, Dekkers D, Muller M, Dijkman R . Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013; 495(7440):251-4. PMC: 7095326. DOI: 10.1038/nature12005. View

Chen Y, Rajashankar K, Yang Y, Agnihothram S, Liu C, Lin Y . Crystal structure of the receptor-binding domain from newly emerged Middle East respiratory syndrome coronavirus. J Virol. 2013; 87(19):10777-83. PMC: 3807420. DOI: 10.1128/JVI.01756-13. View

Wu A, Wang Y, Zeng C, Huang X, Xu S, Su C . Prediction and biochemical analysis of putative cleavage sites of the 3C-like protease of Middle East respiratory syndrome coronavirus. Virus Res. 2015; 208:56-65. PMC: 7114542. DOI: 10.1016/j.virusres.2015.05.018. View

Snijder E, Decroly E, Ziebuhr J . The Nonstructural Proteins Directing Coronavirus RNA Synthesis and Processing. Adv Virus Res. 2016; 96:59-126. PMC: 7112286. DOI: 10.1016/bs.aivir.2016.08.008. View

Wang N, Shi X, Jiang L, Zhang S, Wang D, Tong P . Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res. 2013; 23(8):986-93. PMC: 3731569. DOI: 10.1038/cr.2013.92. View

10.

Azhar E, El-Kafrawy S, Farraj S, Hassan A, Al-Saeed M, Hashem A . Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med. 2014; 370(26):2499-505. DOI: 10.1056/NEJMoa1401505. View

11.

Fehr A, Perlman S . Coronaviruses: an overview of their replication and pathogenesis. Methods Mol Biol. 2015; 1282:1-23. PMC: 4369385. DOI: 10.1007/978-1-4939-2438-7_1. View

12.

Zaki A, van Boheemen S, Bestebroer T, Osterhaus A, Fouchier R . Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012; 367(19):1814-20. DOI: 10.1056/NEJMoa1211721. View

13.

Paden C, Yusof M, Al Hammadi Z, Queen K, Tao Y, Eltahir Y . Zoonotic origin and transmission of Middle East respiratory syndrome coronavirus in the UAE. Zoonoses Public Health. 2017; 65(3):322-333. PMC: 5893383. DOI: 10.1111/zph.12435. View

14.

Patel A, Reuschel E, Xu Z, Zaidi F, Kim K, Scott D . Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirus. JCI Insight. 2021; 6(10). PMC: 8262283. DOI: 10.1172/jci.insight.146082. View

15.

Wang L, Shi W, Joyce M, Modjarrad K, Zhang Y, Leung K . Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015; 6:7712. PMC: 4525294. DOI: 10.1038/ncomms8712. View

16.

Maassab H . Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature. 1967; 213(5076):612-4. DOI: 10.1038/213612a0. View

17.

Yuan S, Balaji S, Lomakin I, Xiong Y . Coronavirus Nsp1: Immune Response Suppression and Protein Expression Inhibition. Front Microbiol. 2021; 12:752214. PMC: 8512706. DOI: 10.3389/fmicb.2021.752214. View

18.

Boyaka P . Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems. J Immunol. 2017; 199(1):9-16. PMC: 5719502. DOI: 10.4049/jimmunol.1601775. View

19.

Yang Y, Du L, Liu C, Wang L, Ma C, Tang J . Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus. Proc Natl Acad Sci U S A. 2014; 111(34):12516-21. PMC: 4151778. DOI: 10.1073/pnas.1405889111. View

20.

Conzade R, Grant R, Malik M, Elkholy A, Elhakim M, Samhouri D . Reported Direct and Indirect Contact with Dromedary Camels among Laboratory-Confirmed MERS-CoV Cases. Viruses. 2018; 10(8). PMC: 6115845. DOI: 10.3390/v10080425. View